Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study - Top-Institutions - MDSpire

Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study

  • By

  • Tim C H Hoogenboom

  • Pablo García Martínez

  • Piyush Mahapatra

  • Nurul Ain Nizar

  • April 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Telemedicine
    • Health Services Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Dermatology
    • Oncology
    • Telehealth

  • #3

    King’s College London, Guy’s and St Thomas’ NHS Foundation Trust
    King’s College London, Guy’s and St Thomas’ NHS Foundation Trust

    London, England

    Key Differentiators

    • Dermatology
    • Digital Health
    • Health Economics

  • #4

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Dermatology
    • Telemedicine
    • Cancer Research

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Dermatology
    • Telehealth
    • Health Policy

Original Source(s)

Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study

  • by Tim C H Hoogenboom, Pablo García Martínez, Piyush Mahapatra, Nurul Ain Nizar

  • April 6, 2026

Related Content

Anti-PD-1 monoclonal antibody combined with chemotherapy for porocarcinoma: a case report and literature review

Methylation-regulated miR-374a-5p and miR-374b-5p Suppress Glycolysis and Malignant Progression of Head and Neck Squamous Cell Carcinoma by Targeting DEPDC1

Efficacy and safety of vismodegib in periocular and orbital basal cell carcinoma: a systematic review and meta-analysis